 |
인쇄하기
취소
|
CJ Launches Chronic Renal Failure Medication
CJ Pharmaceutical Division announced this week that the company makes an official launching of chronic renal failure medication Kremezin in the domestic market starting February 1st, under the exclusive promotion contract withSankyoCo. Ltd.
According to the company, Kremezin, an oral absorbent, removes uremic toxins in the digestive tract and inhibits the progression of renal failure. Cons...
According to the company, Kremezin, an oral absorbent, removes uremic toxins in the digestive tract and inhibits the progression of renal failure. Cons...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.